Category Archives: Parkinson’s Treatment

2021 could very well have been the year of the vaccine.While this modality iscertainly not newvaccines have eradicated smallpox, removed polio from most of the worldand protected us against human papillomavirus (HPV) since 2006the COVID-19 pandemic is sparking excitement about just what else they might be able to do. Continue reading →

Rising prevalence of chronic diseases is predicted to upsurge the demand for stem cell therapies. Prevalence of chronic diseases such as muscular dystrophy, neurological disorders and other diseases is increasing in developed as well as developing regions Continue reading →

MELBOURNE, Australia and SAN FRANCISCO, Jan. Continue reading →

A tribute to the prime time star, who topped theatre bills globally, including more than a thousand solo appearances at the London Palladium will be aired tonight on ITV, with many of his celebrity friends and admirers speaking on the legacy he left behind. Continue reading →

PURCHASE, N.Y., Jan. Continue reading →

TORONTO, Jan. 12, 2022 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the Company or PharmaTher) (OTCQB: PHRRF) (CSE: PHRM), a company focused on the development and commercialization of specialty ketamine prescription-based products, today announced that the U.S Continue reading →

North Oaks Neurology Fellowship-trained and board-certified Neurologist and Epileptologist Najib Murr, M.D., FAAN, has joined North Oaks Neurology Clinic in Hammond. He also is skilled in the diagnosis, treatment and rehabilitation of a wide variety of disorders that affect the nervous system, including headaches, stroke, movement disorders and tremors, Parkinsons disease, Alzheimers disease and multiple sclerosis. Highly regarded in research and education relevant to epilepsy, Murr is fluent in English, French and Arabic and has served on the editorial boards and as a reviewer for multiple peer review journals, including Neurology and Neuroscience Journal and Neurology, Neuroscience Research Journal and International Neuropsychiatric Disease Journal Continue reading →

Without a precise and accurate definition, we may never find a cure. The signature case of Alzheimers disease was a German woman named Auguste whose mental status began to deteriorate to the extent that her husband brought her to a psychiatry clinic in Frankfurt. As is traditional, the scientific literature until very recently referred to Auguste merely by her first name plus the initial of her last name Auguste D. Continue reading →

DUBAI, United Arab Emirates, Jan. 12, 2022 (GLOBE NEWSWIRE) -- In terms of revenue, theglobalBehavioural Health Marketgarnered a value ofUS$ 128.2 Bnand is projected to expand at3.4%CAGR over the forecast period of 2022-2028, and is expected to be valued atUS$ 156.3 Bnby 2028 end. Continue reading →

Parkinsons disease is a neurological condition that gets progressively worse over time and causes trouble with movement. Its thought to affect about 1 percent of people over the age of 65. Parkinsons is caused by the death of cells in a part of your brain called the substantia nigra. Continue reading →